77212184 - C

Information

  • Trademark
  • 77212184
  • Serial Number
    77212184
  • Registration Number
    3849207
  • Filing Date
    June 21, 2007
    17 years ago
  • Registration Date
    September 21, 2010
    13 years ago
  • Transaction Date
    October 09, 2020
    3 years ago
  • Status Date
    October 04, 2019
    4 years ago
  • Published for Opposition Date
    November 17, 2009
    14 years ago
  • Renewal Date
    September 21, 2020
    3 years ago
  • Location Date
    October 04, 2019
    4 years ago
  • Status Code
    800
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    FLETCHER, TRACY L
  • Attorney Name
    Justin L. Sage
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
3000
Mark Identification
C
Case File Statements
  • CC0000: Color is not claimed as a feature of the mark.
  • DM0000: The mark consists of a stylized letter "C" with a vertical line passing through it, with the letter "C" being blurred to the left of the line and clear or in focus to the right of the vertical line.
  • GS0011: Chemicals used in industry and science, diagnostic preparations, reagents and chemical test kits comprised of reagents for chemical analyses and reagents for medical research use for detection of cancerous conditions, neoplastic conditions, inflammatory conditions, infectious conditions, degenerative conditions, genetically aberrant or diseased conditions, proliferatively aberrant or diseased conditions, vascular disease conditions, premalignant conditions, malignant conditions, cancer and inborn errors for scientific or research use
  • GS0051: Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary preparations for the treatment and prevention of neoplastic, inflammatory, infectious, degenerative, genetic and proliferative and vascular diseases and for the treatment of premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds; medical diagnostic reagents and kits comprised of medical diagnostic reagents and assays for detection of cancer and neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases and for the detection of premalignant and malignant cancerous conditions, cancer and inborn errors; medical diagnostic preparations, namely, in-vitro and in-vivo diagnostic test kits, diagnostic immunocytochemical kits, diagnostic immunohistochemical kits, diagnostic histology kits, diagnostic cytology kits, diagnostic liquid-immuno-assay kits, diagnostic solid-phase immuno-assay kits, diagnostic strip-tests, diagnostic dip-stick-tests, point of care tests, diagnostic lateral-flow assay kits, diagnostic flow-through assay kits, diagnostic immuno-chromatographic kits, all of the above-mentioned kits being for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases; medical diagnostic test strips and diagnostic dip-stick tests for use in early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative or vascular diseases
  • GS0101: [ Diagnostic testing machines, namely, point-of-care testing machines, diagnostic liquid-immuno-assay machines, diagnostic immunocytochemical machines, diagnostic immunohistochemical machines, diagnostic histology machines, diagnostic cytology machines, diagnostic solid-phase immuno assay machines, diagnostic ELISA testing machines, diagnostic immuno-chromatographic machines, all of the aforementioned machines being used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic equipment, namely, containers specially designed for storing and transporting medical samples in the nature of tubes, multiwell plates, columns, strips, sticks, brushes, all for sampling of medical samples from body cavities and epithelia; medical syringes, needles for medical use, spatulas for medical samples and medical diagnostic testing, and medical diagnostic testing swabs, cloths, tampons, all for use in sampling, storing, transporting, preparing, enriching, concentrating, testing, analyzing and evaluating biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above; diagnostic nucleic acid detection machines, diagnostic nucleic acid amplification machines, diagnostic immuno-histology machines and diagnostic immuno-cytology machines all used to analyze and/or provide diagnostic test results and used in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification or therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious and genetic diseases associated with cancer, proliferative diseases associated with neoplastics and dysplastic conditions or vascular diseases as indicated above; medical diagnostic apparatuses and instruments, namely, hand-held, table-top and floor-standing centrifugal, gravitational-separating, electrophoretic, chromatographic, conductometric, potentiometric, spectrometric, spectro-photometric, radiologic electromagnetic-resonance, histological, microscopic and in-vivo-imaging machines and apparatuses for use in preparing, enriching, concentrating, testing, analyzing and evaluating of biological material and samples in connection with early diagnosis, prognosis, grading, monitoring, staging, predictive therapy guidance, patient stratification and therapy guidance of premalignant and malignant conditions, cancer, inborn errors and infectious, genetic, proliferative and vascular diseases as indicated above for clinical and medical laboratory use ]
  • GS0421: [ Scientific and technological services and research and design relating thereto, industrial analysis and research services, design and development of computer hardware and software, scientific analysis in the fields of chemistry, biology and molecular biology, laboratory research in the field of molecular biology; laboratory research in the fields of pharmaceutics and food technology; providing research in the fields of pharmaceutical, chemical and diagnostic research; research and development of pharmaceutical products and substances for others; scientific research in the nature of scientific information research services; chemical, biological, molecular biology and pharmacogenomic analysis services ]
  • GS0441: Medical services, veterinary services, medical diagnostic services and provision of medical diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors; veterinary diagnostic services and provision of veterinary diagnostic information in the field of detection of neoplastic, inflammatory, infectious, degenerative, genetic, proliferative and vascular diseases, premalignant and malignant cancerous conditions, cancer and inborn errors in livestock, cattle, pigs, horses, deer, elk, moose, sheep, dogs, cats, mice, rats, monkeys, apes and birds
Case File Event Statements
  • 10/9/2020 - 3 years ago
    66 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/9/2020 - 3 years ago
    65 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/9/2020 - 3 years ago
    64 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/9/2020 - 3 years ago
    63 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/9/2020 - 3 years ago
    62 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/9/2020 - 3 years ago
    61 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/5/2020 - 3 years ago
    60 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/5/2020 - 3 years ago
    59 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 10/5/2020 - 3 years ago
    58 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 10/5/2020 - 3 years ago
    57 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/5/2020 - 3 years ago
    56 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/5/2020 - 3 years ago
    55 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 12/10/2019 - 4 years ago
    54 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 12/10/2019 - 4 years ago
    53 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/4/2019 - 4 years ago
    52 - NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Type: NA89
  • 10/4/2019 - 4 years ago
    51 - REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Type: RNL1
  • 10/4/2019 - 4 years ago
    50 - REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Type: 89AG
  • 10/2/2019 - 4 years ago
    49 - TEAS SECTION 8 & 9 RECEIVED Type: E89R
  • 10/2/2019 - 4 years ago
    48 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/2/2019 - 4 years ago
    47 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/21/2019 - 4 years ago
    46 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2
  • 1/10/2019 - 5 years ago
    45 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/10/2019 - 5 years ago
    44 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/6/2017 - 7 years ago
    43 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 5/6/2017 - 7 years ago
    42 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P
  • 5/5/2017 - 7 years ago
    41 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/20/2017 - 7 years ago
    40 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 3/24/2014 - 10 years ago
    39 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG
  • 3/24/2014 - 10 years ago
    38 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR
  • 4/20/2012 - 12 years ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/20/2012 - 12 years ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/18/2012 - 12 years ago
    35 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/21/2010 - 13 years ago
    34 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/14/2010 - 14 years ago
    33 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 8/9/2010 - 14 years ago
    32 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 8/10/2010 - 14 years ago
    31 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 8/9/2010 - 14 years ago
    30 - TEAS DELETE 1(B) BASIS RECEIVED Type: D1BR
  • 2/9/2010 - 14 years ago
    29 - NOA MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/17/2009 - 14 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/17/2009 - 14 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/9/2009 - 14 years ago
    26 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/7/2009 - 14 years ago
    25 - ASSIGNED TO LIE Type: ALIE
  • 10/6/2009 - 14 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/6/2009 - 14 years ago
    23 - DATA MODIFICATION COMPLETED Type: DMCC
  • 10/4/2009 - 14 years ago
    22 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 10/4/2009 - 14 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/2/2009 - 14 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/30/2009 - 14 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/30/2009 - 14 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 3/31/2009 - 15 years ago
    17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 3/31/2009 - 15 years ago
    16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 3/31/2009 - 15 years ago
    15 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 3/31/2009 - 15 years ago
    14 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 9/29/2008 - 15 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/29/2008 - 15 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/29/2008 - 15 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 5/6/2008 - 16 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/5/2008 - 16 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/6/2008 - 16 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 5/5/2008 - 16 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/4/2007 - 16 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/4/2007 - 16 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/4/2007 - 16 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/24/2007 - 16 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/26/2007 - 17 years ago
    2 - NOTICE OF DESIGN SEARCH CODE MAILED Type: MDSC
  • 6/25/2007 - 17 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP